Unjha Formulations Promoters File Updated SEBI Shareholding Disclosure for April 2026

2 min read     Updated on 02 Apr 2026, 03:51 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Unjha Formulations Limited's promoter group submitted updated shareholding disclosures under SEBI Regulation 31(4), revealing collective holdings of 1654424 shares representing 36.92% of total share capital as on April 1, 2026. The disclosure includes detailed breakdowns of individual promoter holdings and PAN details for regulatory compliance.

powered bylight_fuzz_icon
36670820

*this image is generated using AI for illustrative purposes only.

Unjha Formulations Limited's promoter group has submitted updated mandatory shareholding disclosures to BSE Limited, revealing their collective stake in the pharmaceutical company as on April 1, 2026. The disclosure, filed under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, specifically under Regulation 31(4), provides transparency regarding promoter group holdings exceeding 25% of the company's share capital.

Updated Promoter Group Shareholding Details

The promoter group collectively holds 1654424 shares, representing 36.92% of Unjha Formulations Limited's total share capital and voting rights. The latest disclosure encompasses both direct shareholdings and persons acting in concert (PAC) within the promoter group as on April 1, 2026.

Promoter Name: Relationship Number of Shares Shareholding (%)
Jashodaben Shambhubhai Patel Mother 739900 16.51
Krutiben Mayankkumar Patel Self 667251 14.89
Urveshkumar Shambhubhaipatel Brother 162273 3.62
Neenaben Urveshkumar Patel Brother's Wife 85000 1.89
Total 1654424 36.92

Regulatory Compliance Framework

The disclosure was submitted in compliance with Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The company received disclosures from all promoter group members covering their shareholdings as on April 1, 2026, with the formal submission made to BSE Limited on April 2, 2026.

Key Disclosure Parameters

The filing covers various categories of holdings including equity shares, voting rights, warrants, convertible securities, and other instruments that could entitle holders to receive shares in the target company. All disclosed holdings are in the form of equity shares with no convertible instruments reported.

Company Details: Information
Target Company Unjha Formulations Limited
Stock Exchange BSE Limited
Company Code 531762
Total Promoter Holding 1654424 shares
Percentage of Total Capital 36.92%
Diluted Share Capital 36.92%

Promoter Group Structure and PAN Details

The promoter group comprises family members with defined relationships and individual PAN identifications. The disclosure includes specific PAN numbers for each promoter: Jashodaben Shambhubhai Patel (AFVPP8472P), Krutiben Mayankkumar Patel (AFVPP8468B), Urveshkumar Shambhubhaipatel (ACDPP8625P), and Neenaben Urveshkumar Patel (AFVPP8467Q).

Krutiben Mayankkumar Patel, who serves as Managing Director (DIN: 01866427), holds 14.89% of the company's shares and signed the disclosure documents on behalf of the company. The disclosure ensures transparency in promoter shareholding patterns and compliance with SEBI's substantial acquisition regulations, providing investors with clear visibility into the ownership structure of Unjha Formulations Limited.

Historical Stock Returns for Unjha Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
+3.59%-3.76%-6.87%-19.07%-11.87%+150.00%

Will Unjha Formulations consider raising additional capital through equity dilution given the promoter group's comfortable 36.92% stake?

How might the concentrated family ownership structure impact the company's ability to attract institutional investors or strategic partnerships?

What are the potential succession planning implications for Unjha Formulations given the age distribution within the promoter family?

Unjha Formulations Publishes Q3FY26 Financial Results in Newspapers

2 min read     Updated on 05 Feb 2026, 09:27 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Unjha Formulations Limited announced the newspaper publication of its Q3FY26 unaudited financial results on February 5, 2026, in Free Press (English) and Lokmitra (Gujarati) editions. The results show Q3FY26 net sales of ₹440.77 lacs with 17.15% growth and net profit of ₹23.97 lacs. For nine months, the company reported revenue of ₹1230.71 lacs and profit of ₹144.75 lacs, demonstrating strong performance and regulatory compliance.

powered bylight_fuzz_icon
31741731

*this image is generated using AI for illustrative purposes only.

Unjha Formulations Limited has published its unaudited financial results for the quarter and nine months ended December 31, 2025, in compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The company announced the newspaper publication of these results on February 5, 2026, following board approval during their meeting held on February 4, 2026.

Newspaper Publication Details

The company published its Q3FY26 financial results in two newspapers to ensure regulatory compliance and public disclosure. The publication schedule demonstrates the company's commitment to transparency and adherence to listing requirements.

Publication Details: Information
Free Press: English Edition - February 5, 2026
Lokmitra: Gujarati Edition - February 5, 2026
Regulatory Reference: Regulation 33(3) of SEBI LODR 2015
Board Meeting Date: February 4, 2026

Quarterly Performance Analysis

The company's Q3FY26 performance demonstrated solid growth compared to the corresponding period in the previous year. Net sales increased significantly, while the company maintained operational efficiency despite higher material costs.

Performance Metric: Q3FY26 Q3FY25 Change
Net Sales: ₹440.77 lacs ₹376.24 lacs +17.15%
Total Income from Operations: ₹443.90 lacs ₹377.38 lacs +17.63%
Total Expenditure: ₹419.93 lacs ₹354.98 lacs +18.29%
Net Profit: ₹23.97 lacs ₹22.40 lacs +7.01%
Basic EPS: ₹0.53 ₹0.50 +6.00%

Nine-Month Financial Performance

For the nine-month period ended December 31, 2025, Unjha Formulations showed strong year-over-year growth across key financial metrics. The company's revenue expansion was accompanied by improved profitability margins.

Financial Parameter: 9M FY26 9M FY25 Growth
Net Sales: ₹1230.71 lacs ₹1149.65 lacs +7.05%
Total Operating Income: ₹1242.05 lacs ₹1153.78 lacs +7.65%
Net Profit: ₹144.75 lacs ₹81.21 lacs +78.24%
Basic EPS: ₹3.23 ₹1.81 +78.45%

Regulatory Compliance and Corporate Governance

The financial results were reviewed and approved by the company's Audit Committee and Board of Directors. The limited review was conducted by Jain & Golechha, Chartered Accountants (FRN: 119637W), in accordance with Standard on Review Engagement (SRE) 2410. The company maintains a paid-up equity share capital of ₹448.05 lacs with a face value of ₹10 per share. No investor complaints were pending at the beginning or end of the quarter, reflecting strong corporate governance practices. The results were filed under the company's CIN L99999GJ1994PLC022932 and BSE scrip code 531762.

Management Communication

The publication announcement was signed by Managing Director Krutiben M. Patel (DIN: 01866427), demonstrating proper authorization and management oversight. The company's registered office is located at Khali Char Rasta, State Highway, Sidhpur - 384 151, with contact details including phone numbers +91 9825017696 and +91 9925483654.

Historical Stock Returns for Unjha Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
+3.59%-3.76%-6.87%-19.07%-11.87%+150.00%

More News on Unjha Formulations

1 Year Returns:-11.87%